Abstract:Most (60%-80%) of the oral cavity invasive squamous cell carcinoma (OSCC) demonstrate molecular alterations in TP53. The presence of TP53 mutations in multiple organ systems has been associated with a more aggressive clinical course. This study aimed to classify OSCC into p53 wild-type OSCC and p53-abnormal OSCC using p53 immunohistochemistry and to determine if abnormal p53 status correlates with a higher risk of lymph node metastasis at the time of surgery. A total of 101 patients with OSCC resection and cervical lymph node dissection were identified. p53 immunohistochemistry was performed for all cases and scored into p53 wild-type (p53-HPV: midepithelial/basal sparing, markedly reduced [null-like]/basal sparing; p53-conventional: scattered basal, patchy basal/parabasal) and p53-abnormal (overexpression basal/parabasal only, overexpression basal/parabasal to diffuse, null, and cytoplasmic) patterns. p16 immunohistochemistry and high-risk HPV RNA in situ hybridization were used to confirm the HPV status in cases showing midepithelial/basal sparing or markedly reduced (null-like)/basal sparing pattern. Logistic regression analysis was performed to investigate the association of p53 status, tumor size, depth of invasion, and pT stage against lymph node status. We identified 22 cases with p53 wild-type patterns (16 p53-conventional, 6 p53-HPV) and 79 cases with p53-abnormal patterns. Two of 22 p53 wild-type cases had positive lymph nodes (1 p53-conventional, 1 p53-HPV), whereas 40 of 79 p53-abnormal cases had positive lymph nodes (P < .001). Multivariate analysis showed that p53-abnormal pattern was an independent risk factor associated with positive node(s) with an odds ratio of 8.12 (95% CI, 2.10-53.78; P = .008). p53-Abnormal OSCCs were significantly more likely to be associated with positive lymph node status than p53 wild-type OSCCs at the time of surgery. Further investigation with long-term follow-up is required to determine its clinical application before surgery planning.

Abnormal p53 Immunohistochemical Patterns Are Associated With Regional Lymph Node Metastasis In Oral Cavity Invasive Squamous Cell Carcinoma At Time Of Surgery

Abnormal p53 Immunohistochemical Patterns Are Associated with Regional Lymph Node Metastasis in Oral Cavity Squamous Cell Carcinoma at Time of Surgery

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

Decreased Expression Of Bar Is Correlated With Poor Prognosis In Oral And Oropharyngeal Carcinoma

P57(Kip2) Expression is Related to Carcinogenesis and Tumor Progression in Laryngeal Tissues

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study

Abnormal P16 Expression and Prognostic Significance in Esophageal Squamous Cell Carcinoma.

p53-positive expression in dysplastic surgical margins is a predictor of tumor recurrence in patients with early oral squamous cell carcinoma.

Associations of TP53 Mutations, Codon 72 Polymorphism and Human Papillomavirus in Head and Neck Squamous Cell Carcinoma Patients.

Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.

Diffuse p16 Immunohistochemical Expression in Basaloid 'Human Papillomavirus-Like' Oral Epithelial Lesions May Not Be Human Papillomavirus-Associated

Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

P53 Gene Mutations in Surgical Margins with Esophageal Squamous Cell Carcinoma

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

To correlate the immunohistochemical analysis of p16 and Ki-67 in oral squamous cell carcinoma with the background of oral submucous fibrosis

Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis

Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study

p53 Immunohistochemical Patterns Predict Oral Epithelial Dysplasia Progression

Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma